234 related articles for article (PubMed ID: 24575388)
1. The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs.
Giorgi Rossi P; Baldacchini F; Ronco G
Front Oncol; 2014; 4():20. PubMed ID: 24575388
[TBL] [Abstract][Full Text] [Related]
2. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis.
Racey CS; Withrow DR; Gesink D
Can J Public Health; 2013 Feb; 104(2):e159-66. PubMed ID: 23618210
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.
Madzima TR; Vahabi M; Lofters A
Can Fam Physician; 2017 Aug; 63(8):597-601. PubMed ID: 28807952
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
[TBL] [Abstract][Full Text] [Related]
5. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
6. Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical.
Mittendorf T; Nocon M; Roll S; Mühlberger N; Sroczynski G; Siebert U; Willich SN; von der Schulenburg JM
GMS Health Technol Assess; 2007 Sep; 3():Doc08. PubMed ID: 21289942
[TBL] [Abstract][Full Text] [Related]
7. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
8. Anal dysplasia screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
[TBL] [Abstract][Full Text] [Related]
9. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
Vahabi M; Lofters A
BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
[TBL] [Abstract][Full Text] [Related]
10. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
[TBL] [Abstract][Full Text] [Related]
12. Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany.
Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
GMS Health Technol Assess; 2010 Apr; 6():Doc05. PubMed ID: 21289878
[TBL] [Abstract][Full Text] [Related]
13. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
14. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
15. Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project.
Holme F; Jeronimo J; Maldonado F; Camel C; Sandoval M; Martinez-Granera B; Montenegro M; Figueroa J; Slavkovsky R; Thomson KA; de Sanjose S;
Prev Med; 2020 Jun; 135():106076. PubMed ID: 32247010
[TBL] [Abstract][Full Text] [Related]
16. [Cervical cancer screening with primary HPV-DNA test in the Local Health Authority 2 of Savona (Liguria Region, Northern Italy): a population-based study].
Depetrini E; Bonelli L; Ardoino S; Cirucca MC; Contin R; De Leonardis D; Errigo V; Lugani A; Franco A; Pastorino A; Carrozzi G; Venturino E
Epidemiol Prev; 2016; 40(3-4):171-8. PubMed ID: 27436250
[TBL] [Abstract][Full Text] [Related]
17. Women's experience with home-based self-sampling for human papillomavirus testing.
Sultana F; Mullins R; English DR; Simpson JA; Drennan KT; Heley S; Wrede CD; Brotherton JM; Saville M; Gertig DM
BMC Cancer; 2015 Nov; 15():849. PubMed ID: 26536865
[TBL] [Abstract][Full Text] [Related]
18. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.
Dzuba IG; Díaz EY; Allen B; Leonard YF; Lazcano Ponce EC; Shah KV; Bishai D; Lorincz A; Ferris D; Turnbull B; Hernández Avila M; Salmerón J
J Womens Health Gend Based Med; 2002 Apr; 11(3):265-75. PubMed ID: 11988136
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the self-sampling for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Cáceres L; Bellot D; Ovando N; Torrico A; Calle P; Ascarrunz C; Alexander S; Bossens M; Fontaine V; Rodríguez P
BMC Public Health; 2019 Jan; 19(1):80. PubMed ID: 30654774
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
